Goldman Sachs raises Centene stock price target to $38 despite Sell rating

Investing.comThursday, October 30, 2025 at 11:27:20 AM
Goldman Sachs raises Centene stock price target to $38 despite Sell rating
Goldman Sachs has raised its price target for Centene's stock to $38, even while maintaining a 'Sell' rating. This move indicates a cautious optimism about Centene's future performance, suggesting that while the stock may not be a buy right now, there is potential for growth. Investors will be watching closely to see how Centene navigates upcoming challenges and whether it can meet this new target.
— Curated by the World Pulse Now AI Editorial System

Was this article worth reading? Share it

Recommended Readings
Goldman Sachs raises Nio stock price target to $7 on improved model competitiveness
PositiveFinancial Markets
Goldman Sachs has raised its price target for Nio's stock to $7, citing improvements in the company's model competitiveness. This adjustment reflects growing confidence in Nio's ability to compete effectively in the electric vehicle market, which is crucial for attracting investors and boosting stock performance. As the EV sector continues to evolve, Nio's advancements could position it favorably against rivals, making this news significant for stakeholders and potential investors.
Chipotle stock price target lowered to $45 by Goldman Sachs on inflation concerns
NegativeFinancial Markets
Goldman Sachs has lowered its stock price target for Chipotle to $45, citing concerns over inflation that could impact the company's profitability. This adjustment reflects broader economic challenges that may affect consumer spending and food prices, making it a significant development for investors and stakeholders in the fast-casual dining sector.
Goldman Sachs downgrades Fiserv stock to Neutral on earnings reset
NegativeFinancial Markets
Goldman Sachs has downgraded Fiserv's stock to neutral following an earnings reset, signaling potential concerns about the company's financial outlook. This decision is significant as it reflects the investment bank's cautious stance on Fiserv's future performance, which could impact investor confidence and stock prices. Such downgrades often lead to increased scrutiny from investors and analysts alike.
Goldman Sachs raises Alphabet stock price target to $330 on strong cloud growth
PositiveFinancial Markets
Goldman Sachs has raised its price target for Alphabet's stock to $330, reflecting strong growth in its cloud services. This adjustment highlights the increasing importance of cloud computing in Alphabet's overall business strategy and signals confidence in the company's future performance. Investors may see this as a positive indicator of Alphabet's ability to capitalize on the growing demand for cloud solutions.
West a decade behind China on rare earths – Goldman Sachs
NegativeFinancial Markets
Goldman Sachs has highlighted a significant gap in rare earth processing capabilities between the West and China, suggesting that it may take Western producers up to a decade to catch up. This delay is concerning as rare earths are crucial for various high-tech industries, including electronics and renewable energy. The implications of this lag could affect global supply chains and technological advancements, making it a critical issue for economic competitiveness.
Wall Street is in a risk-on mood as it waits for Powell to deliver on the ‘Fed put’
PositiveFinancial Markets
Wall Street is currently experiencing a positive shift in sentiment as investors await comments from Federal Reserve Chair Jerome Powell regarding the anticipated 'Fed put.' This shift indicates a growing confidence in the market, suggesting that investors believe the Fed will take measures to support the economy if needed. Such optimism can lead to increased investment and stability in the financial markets, making it a significant moment for both investors and the broader economy.
Goldman Sachs discloses trading position in Avadel Pharmaceuticals
NeutralFinancial Markets
Goldman Sachs has revealed its trading position in Avadel Pharmaceuticals, a move that highlights the investment bank's interest in the pharmaceutical sector. This disclosure is significant as it may influence market perceptions and investor confidence in Avadel, especially given the ongoing developments in the healthcare industry. Understanding such positions can provide insights into market trends and the strategic interests of major financial institutions.
Centene Swings to Loss on Writedown
NegativeFinancial Markets
Centene has reported a significant loss in the third quarter, primarily due to increased medical care costs among enrollees in Affordable Care Act plans. This trend highlights the ongoing challenges faced by health insurers as they attempt to return to profitability amidst rising healthcare expenses. Understanding these financial shifts is crucial for stakeholders in the healthcare industry, as they may impact future policy decisions and insurance options for consumers.
Latest from Financial Markets
Eurozone Economy Picks Up Speed as Hopes for Revival Gather Pace
PositiveFinancial Markets
The Eurozone economy is showing signs of recovery, with GDP growth rising to 0.2% in the third quarter, up from 0.1% in the previous quarter. This improvement is significant as it indicates the 20-nation bloc is adapting to the challenges posed by higher U.S. tariffs. A stronger economy can lead to increased consumer confidence and investment, which is crucial for long-term stability and growth.
Earnings call transcript: Vulcan Materials Q3 2025 shows strong EPS beat
PositiveFinancial Markets
Vulcan Materials has reported a strong earnings performance for Q3 2025, significantly beating expectations with its earnings per share (EPS). This positive result highlights the company's robust operational efficiency and market demand for its products, which is crucial for investors and stakeholders. The strong EPS not only reflects the company's financial health but also positions it favorably for future growth, making it an important update for those following the construction materials sector.
Earnings call transcript: Valaris Q3 2025 highlights strong contract wins
PositiveFinancial Markets
Valaris has reported impressive contract wins during its Q3 2025 earnings call, showcasing the company's strong position in the market. This is significant as it reflects Valaris's ability to secure new business in a competitive environment, which could lead to increased revenue and growth opportunities in the future.
PSI reports revenue growth amid one-time expenses in Q3
PositiveFinancial Markets
PSI has reported a notable revenue growth in the third quarter, despite facing some one-time expenses. This growth is significant as it reflects the company's resilience and ability to adapt to financial challenges, which is encouraging for investors and stakeholders. It shows that PSI is on a positive trajectory, potentially leading to more robust performance in the future.
Delek US Energy stock hits 52-week high at 39.29 USD
PositiveFinancial Markets
Delek US Energy's stock has reached a remarkable 52-week high of $39.29, reflecting strong investor confidence and positive market trends. This milestone is significant as it indicates the company's robust performance and potential for future growth, making it an attractive option for investors looking to capitalize on energy sector opportunities.
Earnings call transcript: Hanover Insurance Q3 2025 beats EPS forecasts
PositiveFinancial Markets
Hanover Insurance has reported its Q3 2025 earnings, surpassing EPS forecasts, which is a positive sign for investors and stakeholders. This performance indicates the company's strong financial health and effective management strategies, making it a noteworthy player in the insurance sector. Such results can boost investor confidence and potentially lead to increased stock value.